vs
Braze, Inc.（BRZE）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Braze, Inc.的1.0倍（$197.9M vs $190.8M），REPLIGEN CORP净利率更高（6.7% vs -18.9%，领先25.6%），Braze, Inc.同比增速更快（25.5% vs 13.6%），Braze, Inc.自由现金流更多（$19.0M vs $17.6M），过去两年Braze, Inc.的营收复合增速更高（20.7% vs 14.4%）
Braze是一家总部位于美国纽约的云软件企业，专注于客户互动平台开发，旗下产品可帮助企业开展多渠道营销活动，为品牌与用户的高效连接提供技术支持。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BRZE vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.0倍
$190.8M
营收增速更快
BRZE
高出11.9%
13.6%
净利率更高
RGEN
高出25.6%
-18.9%
自由现金流更多
BRZE
多$1.5M
$17.6M
两年增速更快
BRZE
近两年复合增速
14.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $190.8M | $197.9M |
| 净利润 | $-36.0M | $13.3M |
| 毛利率 | 67.2% | 52.5% |
| 营业利润率 | -19.7% | 9.0% |
| 净利率 | -18.9% | 6.7% |
| 营收同比 | 25.5% | 13.6% |
| 净利润同比 | -29.0% | 143.9% |
| 每股收益（稀释后） | $-0.33 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRZERGEN
| Q4 25 | $190.8M | $197.9M | ||
| Q3 25 | $180.1M | $188.8M | ||
| Q2 25 | $162.1M | $182.4M | ||
| Q1 25 | $160.4M | $169.2M | ||
| Q4 24 | $152.1M | $174.1M | ||
| Q3 24 | $145.5M | $154.9M | ||
| Q2 24 | $135.5M | $154.1M | ||
| Q1 24 | $131.0M | $151.3M |
净利润BRZERGEN
| Q4 25 | $-36.0M | $13.3M | ||
| Q3 25 | $-27.9M | $14.9M | ||
| Q2 25 | $-35.8M | $14.9M | ||
| Q1 25 | $-17.2M | $5.8M | ||
| Q4 24 | $-27.9M | $-30.3M | ||
| Q3 24 | $-23.0M | $-654.0K | ||
| Q2 24 | $-35.6M | $3.3M | ||
| Q1 24 | $-28.3M | $2.1M |
毛利率BRZERGEN
| Q4 25 | 67.2% | 52.5% | ||
| Q3 25 | 67.7% | 53.2% | ||
| Q2 25 | 68.6% | 50.0% | ||
| Q1 25 | 69.3% | 53.6% | ||
| Q4 24 | 69.8% | 26.1% | ||
| Q3 24 | 70.2% | 50.0% | ||
| Q2 24 | 67.1% | 49.8% | ||
| Q1 24 | 67.2% | 49.5% |
营业利润率BRZERGEN
| Q4 25 | -19.7% | 9.0% | ||
| Q3 25 | -21.5% | 8.9% | ||
| Q2 25 | -24.8% | 7.6% | ||
| Q1 25 | -13.4% | 3.9% | ||
| Q4 24 | -21.4% | -17.7% | ||
| Q3 24 | -19.2% | -5.1% | ||
| Q2 24 | -29.6% | 1.0% | ||
| Q1 24 | -24.7% | 1.3% |
净利率BRZERGEN
| Q4 25 | -18.9% | 6.7% | ||
| Q3 25 | -15.5% | 7.9% | ||
| Q2 25 | -22.1% | 8.2% | ||
| Q1 25 | -10.7% | 3.4% | ||
| Q4 24 | -18.4% | -17.4% | ||
| Q3 24 | -15.8% | -0.4% | ||
| Q2 24 | -26.3% | 2.2% | ||
| Q1 24 | -21.6% | 1.4% |
每股收益（稀释后）BRZERGEN
| Q4 25 | $-0.33 | $0.24 | ||
| Q3 25 | $-0.26 | $0.26 | ||
| Q2 25 | $-0.34 | $0.26 | ||
| Q1 25 | $-0.17 | $0.10 | ||
| Q4 24 | $-0.27 | $-0.55 | ||
| Q3 24 | $-0.23 | $-0.01 | ||
| Q2 24 | $-0.35 | $0.06 | ||
| Q1 24 | $-0.28 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.8M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $602.0M | $2.1B |
| 总资产 | $1.0B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BRZERGEN
| Q4 25 | $97.8M | $767.6M | ||
| Q3 25 | $81.0M | $748.7M | ||
| Q2 25 | $231.5M | $708.9M | ||
| Q1 25 | $83.1M | $697.2M | ||
| Q4 24 | $61.3M | $757.4M | ||
| Q3 24 | $79.1M | $784.0M | ||
| Q2 24 | $74.8M | $809.1M | ||
| Q1 24 | $68.2M | $780.6M |
总债务BRZERGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BRZERGEN
| Q4 25 | $602.0M | $2.1B | ||
| Q3 25 | $598.9M | $2.1B | ||
| Q2 25 | $474.4M | $2.1B | ||
| Q1 25 | $474.9M | $2.0B | ||
| Q4 24 | $458.1M | $2.0B | ||
| Q3 24 | $453.7M | $2.0B | ||
| Q2 24 | $436.1M | $2.0B | ||
| Q1 24 | $444.2M | $2.0B |
总资产BRZERGEN
| Q4 25 | $1.0B | $2.9B | ||
| Q3 25 | $1.0B | $2.9B | ||
| Q2 25 | $889.1M | $2.9B | ||
| Q1 25 | $871.0M | $2.9B | ||
| Q4 24 | $842.0M | $2.8B | ||
| Q3 24 | $825.6M | $2.8B | ||
| Q2 24 | $816.1M | $2.9B | ||
| Q1 24 | $810.9M | $2.8B |
负债/权益比BRZERGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $19.0M | $17.6M |
| 自由现金流率自由现金流/营收 | 10.0% | 8.9% |
| 资本支出强度资本支出/营收 | 1.0% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $63.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BRZERGEN
| Q4 25 | $21.0M | $25.7M | ||
| Q3 25 | $7.0M | $48.1M | ||
| Q2 25 | $24.1M | $28.6M | ||
| Q1 25 | $17.1M | $15.0M | ||
| Q4 24 | $-11.4M | $39.2M | ||
| Q3 24 | $11.6M | $49.3M | ||
| Q2 24 | $19.4M | $42.2M | ||
| Q1 24 | $3.8M | $44.7M |
自由现金流BRZERGEN
| Q4 25 | $19.0M | $17.6M | ||
| Q3 25 | $4.3M | $43.4M | ||
| Q2 25 | $23.9M | $21.5M | ||
| Q1 25 | $16.0M | $11.4M | ||
| Q4 24 | $-13.3M | $33.6M | ||
| Q3 24 | $8.3M | $42.3M | ||
| Q2 24 | $12.5M | $37.4M | ||
| Q1 24 | $-2.5M | $36.4M |
自由现金流率BRZERGEN
| Q4 25 | 10.0% | 8.9% | ||
| Q3 25 | 2.4% | 23.0% | ||
| Q2 25 | 14.8% | 11.8% | ||
| Q1 25 | 10.0% | 6.8% | ||
| Q4 24 | -8.8% | 19.3% | ||
| Q3 24 | 5.7% | 27.3% | ||
| Q2 24 | 9.2% | 24.3% | ||
| Q1 24 | -1.9% | 24.0% |
资本支出强度BRZERGEN
| Q4 25 | 1.0% | 4.1% | ||
| Q3 25 | 1.4% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.7% | 2.1% | ||
| Q4 24 | 1.3% | 3.2% | ||
| Q3 24 | 2.3% | 4.5% | ||
| Q2 24 | 5.1% | 3.1% | ||
| Q1 24 | 4.8% | 5.5% |
现金转化率BRZERGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRZE
| Subscription Revenue | $181.7M | 95% |
| Professional Services Revenue | $9.2M | 5% |
RGEN
暂无分部数据
